The global market for Hospital Acquired Disease Testing was valued at US$ 561 million in the year 2024 and is projected to reach a revised size of US$ 1177 million by 2031, growing at a CAGR of 11.3% during the forecast period.

Hospital Acquired Disease Testing Market

Hosptial infection is categorized based on infection types into the following segments: blood stream infection (BSI) testing, urinary tract infection (UTI) testing, methicilin-resistant staphylococcus aureus (MRSA) testing, pneumonia testing, surgical site infection (SSI) testing & others infections such as cardio vascular infection, gastrointestinal infections & respiratory infections.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report aims to provide a comprehensive presentation of the global market for Hospital Acquired Disease Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hospital Acquired Disease Testing.

The Hospital Acquired Disease Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hospital Acquired Disease Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Hospital Acquired Disease Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Hospital Acquired Disease Testing Market Report

Report Metric	Details
Report Name	Hospital Acquired Disease Testing Market
Accounted market size in year	US$ 561 million
Forecasted market size in 2031	US$ 1177 million
CAGR	11.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Instrument and Reagents Consumables
Segment by Application	Disease Testing Drug-Resistance Testing
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Life technologies, Diatherix laboratories, Qiagen GmbH, Meridian Biosciences, Nordion, Roche, Cantel Medical Corporation, Cepheid
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hospital Acquired Disease Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Hospital Acquired Disease Testing Market growing?

Ans: The Hospital Acquired Disease Testing Market witnessing a CAGR of 11.3% during the forecast period 2025-2031.

What is the Hospital Acquired Disease Testing Market size in 2031?

Ans: The Hospital Acquired Disease Testing Market size in 2031 will be US$ 1177 million.

Who are the main players in the Hospital Acquired Disease Testing Market report?

Ans: The main players in the Hospital Acquired Disease Testing Market are Life technologies, Diatherix laboratories, Qiagen GmbH, Meridian Biosciences, Nordion, Roche, Cantel Medical Corporation, Cepheid

What are the Application segmentation covered in the Hospital Acquired Disease Testing Market report?

Ans: The Applications covered in the Hospital Acquired Disease Testing Market report are Disease Testing, Drug-Resistance Testing

What are the Type segmentation covered in the Hospital Acquired Disease Testing Market report?

Ans: The Types covered in the Hospital Acquired Disease Testing Market report are Instrument and Reagents, Consumables

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Hospital Acquired Disease Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Instrument and Reagents

1.2.3 Consumables

1.3 Market by Application

1.3.1 Global Hospital Acquired Disease Testing Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Disease Testing

1.3.3 Drug-Resistance Testing

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Hospital Acquired Disease Testing Market Perspective (2020-2031)

2.2 Global Hospital Acquired Disease Testing Growth Trends by Region

2.2.1 Global Hospital Acquired Disease Testing Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Hospital Acquired Disease Testing Historic Market Size by Region (2020-2025)

2.2.3 Hospital Acquired Disease Testing Forecasted Market Size by Region (2026-2031)

2.3 Hospital Acquired Disease Testing Market Dynamics

2.3.1 Hospital Acquired Disease Testing Industry Trends

2.3.2 Hospital Acquired Disease Testing Market Drivers

2.3.3 Hospital Acquired Disease Testing Market Challenges

2.3.4 Hospital Acquired Disease Testing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Hospital Acquired Disease Testing Players by Revenue

3.1.1 Global Top Hospital Acquired Disease Testing Players by Revenue (2020-2025)

3.1.2 Global Hospital Acquired Disease Testing Revenue Market Share by Players (2020-2025)

3.2 Global Hospital Acquired Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Hospital Acquired Disease Testing Revenue

3.4 Global Hospital Acquired Disease Testing Market Concentration Ratio

3.4.1 Global Hospital Acquired Disease Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Hospital Acquired Disease Testing Revenue in 2024

3.5 Global Key Players of Hospital Acquired Disease Testing Head office and Area Served

3.6 Global Key Players of Hospital Acquired Disease Testing, Product and Application

3.7 Global Key Players of Hospital Acquired Disease Testing, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Hospital Acquired Disease Testing Breakdown Data by Type

4.1 Global Hospital Acquired Disease Testing Historic Market Size by Type (2020-2025)

4.2 Global Hospital Acquired Disease Testing Forecasted Market Size by Type (2026-2031)

5 Hospital Acquired Disease Testing Breakdown Data by Application

5.1 Global Hospital Acquired Disease Testing Historic Market Size by Application (2020-2025)

5.2 Global Hospital Acquired Disease Testing Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Hospital Acquired Disease Testing Market Size (2020-2031)

6.2 North America Hospital Acquired Disease Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Hospital Acquired Disease Testing Market Size by Country (2020-2025)

6.4 North America Hospital Acquired Disease Testing Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Hospital Acquired Disease Testing Market Size (2020-2031)

7.2 Europe Hospital Acquired Disease Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Hospital Acquired Disease Testing Market Size by Country (2020-2025)

7.4 Europe Hospital Acquired Disease Testing Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Hospital Acquired Disease Testing Market Size (2020-2031)

8.2 Asia-Pacific Hospital Acquired Disease Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Hospital Acquired Disease Testing Market Size by Region (2020-2025)

8.4 Asia-Pacific Hospital Acquired Disease Testing Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Hospital Acquired Disease Testing Market Size (2020-2031)

9.2 Latin America Hospital Acquired Disease Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Hospital Acquired Disease Testing Market Size by Country (2020-2025)

9.4 Latin America Hospital Acquired Disease Testing Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Hospital Acquired Disease Testing Market Size (2020-2031)

10.2 Middle East & Africa Hospital Acquired Disease Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Hospital Acquired Disease Testing Market Size by Country (2020-2025)

10.4 Middle East & Africa Hospital Acquired Disease Testing Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Life technologies

11.1.1 Life technologies Company Details

11.1.2 Life technologies Business Overview

11.1.3 Life technologies Hospital Acquired Disease Testing Introduction

11.1.4 Life technologies Revenue in Hospital Acquired Disease Testing Business (2020-2025)

11.1.5 Life technologies Recent Development

11.2 Diatherix laboratories

11.2.1 Diatherix laboratories Company Details

11.2.2 Diatherix laboratories Business Overview

11.2.3 Diatherix laboratories Hospital Acquired Disease Testing Introduction

11.2.4 Diatherix laboratories Revenue in Hospital Acquired Disease Testing Business (2020-2025)

11.2.5 Diatherix laboratories Recent Development

11.3 Qiagen GmbH

11.3.1 Qiagen GmbH Company Details

11.3.2 Qiagen GmbH Business Overview

11.3.3 Qiagen GmbH Hospital Acquired Disease Testing Introduction

11.3.4 Qiagen GmbH Revenue in Hospital Acquired Disease Testing Business (2020-2025)

11.3.5 Qiagen GmbH Recent Development

11.4 Meridian Biosciences

11.4.1 Meridian Biosciences Company Details

11.4.2 Meridian Biosciences Business Overview

11.4.3 Meridian Biosciences Hospital Acquired Disease Testing Introduction

11.4.4 Meridian Biosciences Revenue in Hospital Acquired Disease Testing Business (2020-2025)

11.4.5 Meridian Biosciences Recent Development

11.5 Nordion

11.5.1 Nordion Company Details

11.5.2 Nordion Business Overview

11.5.3 Nordion Hospital Acquired Disease Testing Introduction

11.5.4 Nordion Revenue in Hospital Acquired Disease Testing Business (2020-2025)

11.5.5 Nordion Recent Development

11.6 Roche

11.6.1 Roche Company Details

11.6.2 Roche Business Overview

11.6.3 Roche Hospital Acquired Disease Testing Introduction

11.6.4 Roche Revenue in Hospital Acquired Disease Testing Business (2020-2025)

11.6.5 Roche Recent Development

11.7 Cantel Medical Corporation

11.7.1 Cantel Medical Corporation Company Details

11.7.2 Cantel Medical Corporation Business Overview

11.7.3 Cantel Medical Corporation Hospital Acquired Disease Testing Introduction

11.7.4 Cantel Medical Corporation Revenue in Hospital Acquired Disease Testing Business (2020-2025)

11.7.5 Cantel Medical Corporation Recent Development

11.8 Cepheid

11.8.1 Cepheid Company Details

11.8.2 Cepheid Business Overview

11.8.3 Cepheid Hospital Acquired Disease Testing Introduction

11.8.4 Cepheid Revenue in Hospital Acquired Disease Testing Business (2020-2025)

11.8.5 Cepheid Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Diatherix Laboratories

Qiagen NV

Meridian Biosciences

Nordion

Cantel Medical Corporation

Cepheid Inc

Life Technologies

Roche

List of Tables

Table 1. Global Hospital Acquired Disease Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Instrument and Reagents

Table 3. Key Players of Consumables

Table 4. Global Hospital Acquired Disease Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Hospital Acquired Disease Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Hospital Acquired Disease Testing Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Hospital Acquired Disease Testing Market Share by Region (2020-2025)

Table 8. Global Hospital Acquired Disease Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Hospital Acquired Disease Testing Market Share by Region (2026-2031)

Table 10. Hospital Acquired Disease Testing Market Trends

Table 11. Hospital Acquired Disease Testing Market Drivers

Table 12. Hospital Acquired Disease Testing Market Challenges

Table 13. Hospital Acquired Disease Testing Market Restraints

Table 14. Global Hospital Acquired Disease Testing Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Hospital Acquired Disease Testing Market Share by Players (2020-2025)

Table 16. Global Top Hospital Acquired Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital Acquired Disease Testing as of 2024)

Table 17. Ranking of Global Top Hospital Acquired Disease Testing Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Hospital Acquired Disease Testing Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Hospital Acquired Disease Testing, Headquarters and Area Served

Table 20. Global Key Players of Hospital Acquired Disease Testing, Product and Application

Table 21. Global Key Players of Hospital Acquired Disease Testing, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Hospital Acquired Disease Testing Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Hospital Acquired Disease Testing Revenue Market Share by Type (2020-2025)

Table 25. Global Hospital Acquired Disease Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Hospital Acquired Disease Testing Revenue Market Share by Type (2026-2031)

Table 27. Global Hospital Acquired Disease Testing Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Hospital Acquired Disease Testing Revenue Market Share by Application (2020-2025)

Table 29. Global Hospital Acquired Disease Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Hospital Acquired Disease Testing Revenue Market Share by Application (2026-2031)

Table 31. North America Hospital Acquired Disease Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Hospital Acquired Disease Testing Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Hospital Acquired Disease Testing Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Hospital Acquired Disease Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Hospital Acquired Disease Testing Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Hospital Acquired Disease Testing Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Hospital Acquired Disease Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Hospital Acquired Disease Testing Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Hospital Acquired Disease Testing Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Hospital Acquired Disease Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Hospital Acquired Disease Testing Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Hospital Acquired Disease Testing Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Hospital Acquired Disease Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Hospital Acquired Disease Testing Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Hospital Acquired Disease Testing Market Size by Country (2026-2031) & (US$ Million)

Table 46. Life technologies Company Details

Table 47. Life technologies Business Overview

Table 48. Life technologies Hospital Acquired Disease Testing Product

Table 49. Life technologies Revenue in Hospital Acquired Disease Testing Business (2020-2025) & (US$ Million)

Table 50. Life technologies Recent Development

Table 51. Diatherix laboratories Company Details

Table 52. Diatherix laboratories Business Overview

Table 53. Diatherix laboratories Hospital Acquired Disease Testing Product

Table 54. Diatherix laboratories Revenue in Hospital Acquired Disease Testing Business (2020-2025) & (US$ Million)

Table 55. Diatherix laboratories Recent Development

Table 56. Qiagen GmbH Company Details

Table 57. Qiagen GmbH Business Overview

Table 58. Qiagen GmbH Hospital Acquired Disease Testing Product

Table 59. Qiagen GmbH Revenue in Hospital Acquired Disease Testing Business (2020-2025) & (US$ Million)

Table 60. Qiagen GmbH Recent Development

Table 61. Meridian Biosciences Company Details

Table 62. Meridian Biosciences Business Overview

Table 63. Meridian Biosciences Hospital Acquired Disease Testing Product

Table 64. Meridian Biosciences Revenue in Hospital Acquired Disease Testing Business (2020-2025) & (US$ Million)

Table 65. Meridian Biosciences Recent Development

Table 66. Nordion Company Details

Table 67. Nordion Business Overview

Table 68. Nordion Hospital Acquired Disease Testing Product

Table 69. Nordion Revenue in Hospital Acquired Disease Testing Business (2020-2025) & (US$ Million)

Table 70. Nordion Recent Development

Table 71. Roche Company Details

Table 72. Roche Business Overview

Table 73. Roche Hospital Acquired Disease Testing Product

Table 74. Roche Revenue in Hospital Acquired Disease Testing Business (2020-2025) & (US$ Million)

Table 75. Roche Recent Development

Table 76. Cantel Medical Corporation Company Details

Table 77. Cantel Medical Corporation Business Overview

Table 78. Cantel Medical Corporation Hospital Acquired Disease Testing Product

Table 79. Cantel Medical Corporation Revenue in Hospital Acquired Disease Testing Business (2020-2025) & (US$ Million)

Table 80. Cantel Medical Corporation Recent Development

Table 81. Cepheid Company Details

Table 82. Cepheid Business Overview

Table 83. Cepheid Hospital Acquired Disease Testing Product

Table 84. Cepheid Revenue in Hospital Acquired Disease Testing Business (2020-2025) & (US$ Million)

Table 85. Cepheid Recent Development

Table 86. Research Programs/Design for This Report

Table 87. Key Data Information from Secondary Sources

Table 88. Key Data Information from Primary Sources

Table 89. Authors List of This Report

List of Figures

Figure 1. Hospital Acquired Disease Testing Picture

Figure 2. Global Hospital Acquired Disease Testing Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Hospital Acquired Disease Testing Market Share by Type: 2024 VS 2031

Figure 4. Instrument and Reagents Features

Figure 5. Consumables Features

Figure 6. Global Hospital Acquired Disease Testing Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Hospital Acquired Disease Testing Market Share by Application: 2024 VS 2031

Figure 8. Disease Testing Case Studies

Figure 9. Drug-Resistance Testing Case Studies

Figure 10. Hospital Acquired Disease Testing Report Years Considered

Figure 11. Global Hospital Acquired Disease Testing Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 12. Global Hospital Acquired Disease Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Hospital Acquired Disease Testing Market Share by Region: 2024 VS 2031

Figure 14. Global Hospital Acquired Disease Testing Market Share by Players in 2024

Figure 15. Global Top Hospital Acquired Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital Acquired Disease Testing as of 2024)

Figure 16. The Top 10 and 5 Players Market Share by Hospital Acquired Disease Testing Revenue in 2024

Figure 17. North America Hospital Acquired Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 18. North America Hospital Acquired Disease Testing Market Share by Country (2020-2031)

Figure 19. United States Hospital Acquired Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. Canada Hospital Acquired Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Europe Hospital Acquired Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Hospital Acquired Disease Testing Market Share by Country (2020-2031)

Figure 23. Germany Hospital Acquired Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. France Hospital Acquired Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. U.K. Hospital Acquired Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Italy Hospital Acquired Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Russia Hospital Acquired Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Nordic Countries Hospital Acquired Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Asia-Pacific Hospital Acquired Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Hospital Acquired Disease Testing Market Share by Region (2020-2031)

Figure 31. China Hospital Acquired Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Japan Hospital Acquired Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. South Korea Hospital Acquired Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Southeast Asia Hospital Acquired Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. India Hospital Acquired Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Australia Hospital Acquired Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Latin America Hospital Acquired Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Hospital Acquired Disease Testing Market Share by Country (2020-2031)

Figure 39. Mexico Hospital Acquired Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Brazil Hospital Acquired Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Middle East & Africa Hospital Acquired Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Hospital Acquired Disease Testing Market Share by Country (2020-2031)

Figure 43. Turkey Hospital Acquired Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Saudi Arabia Hospital Acquired Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. UAE Hospital Acquired Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Life technologies Revenue Growth Rate in Hospital Acquired Disease Testing Business (2020-2025)

Figure 47. Diatherix laboratories Revenue Growth Rate in Hospital Acquired Disease Testing Business (2020-2025)

Figure 48. Qiagen GmbH Revenue Growth Rate in Hospital Acquired Disease Testing Business (2020-2025)

Figure 49. Meridian Biosciences Revenue Growth Rate in Hospital Acquired Disease Testing Business (2020-2025)

Figure 50. Nordion Revenue Growth Rate in Hospital Acquired Disease Testing Business (2020-2025)

Figure 51. Roche Revenue Growth Rate in Hospital Acquired Disease Testing Business (2020-2025)

Figure 52. Cantel Medical Corporation Revenue Growth Rate in Hospital Acquired Disease Testing Business (2020-2025)

Figure 53. Cepheid Revenue Growth Rate in Hospital Acquired Disease Testing Business (2020-2025)

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

Figure 56. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions